Scientists identify reversible molecular defect underlying rheumatoid arthritis

Scientists Identify Reversible Molecular Defect Underlying Rheumatoid Arthritis blogpost is one based on this Health and Medical Updates categories, written with our author Linda Norton over February 5, 2019, these article can search just after this tags list arthritis, defect, identify, molecular, reversible, rheumatoid, Scientists, underlying. We are blissful to pleased you and providing these anothers section about health and we always posting the section frequenlty.

Tcell.jpg

Scanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIH

In rheumatoid arthritis, immune cells called helper T cells behave differently from their counterparts in healthy cells and in other autoimmune diseases. Stanford scientists have learned why.

Stanford University School of Medicine investigators succeeded in countering inflammation and tissue damage caused by rheumatoid arthritis in mice engrafted with human joint-lining tissue and a human immune system.

The researchers accomplished this by shutting down a faulty molecular mechanism that they identified in humans with the disease.

In addition, they found that a novel drug, which is not yet commercially available, helped protect both human cells in a dish and the humanized mice from rheumatoid arthritis. Clinical trials of the drug or a closely related compound could begin in the near future.

The findings were published online Feb. 4 in Nature Immunology. Cornelia Weyand, MD, Ph.D., professor and chief of immunology and rheumatology, is the senior author. The lead author is postdoctoral scholar Zhenke Wen, MD, Ph.D.

Rheumatoid arthritis is one of the most common autoimmune diseases, affecting about 1 percent of the population. It involves destruction of synovia, soft tissue that lubricates joints to prevent bones from scraping together. Whereas osteoarthritis is attributable to age-related wear and tear, rheumatoid arthritis results from a chronic attack on the synovia by cells of the body’s immune system. The inflammatory character of rheumatoid arthritis also causes systemic problems. For example, it doubles the risk of heart disease.

Existing rheumatoid-arthritis medications relieve symptoms but don’t actually eradicate the disease by rectifying the behavior of the immune cells causing it, Weyand said. Why those cells go on the attack to begin with has been mysterious.

But Weyand’s team has clues. “We’ve learned that rheumatoid arthritis is, at root, a problem of faulty cell metabolism and, in particular, of one type of immune cell’s inappropriate diversion of resources from generating energy to the production of an army of inflammatory offspring,” she said. This cellular army exits the lymph nodes, makes its way to synovial tissues, takes up residence there and instigates the inflammatory damage that’s the hallmark of rheumatoid arthritis.

“We know how these immune cells fuel their bad behavior,” Weyand said. “And now we’ve shown we can reverse this behavior and make these cells behave as they should.”

Errant helper T cells

The errant cells are helper T cells. After infiltrating synovial tissue, they send out signals that call in other super-aggressive immune cells and cause ordinary synovial cells to become inflamed and destructive.

In prior work, Weyand’s group noticed telling differences between the helper T cells of patients with rheumatoid arthritis and those of healthy people. The former, for instance, have low reserves of a molecule called ATP, which serves as cell’s internal energy currency, accepted by all of a cell’s myriad metabolic enterprises. Yet instead of directing their primary energy source, glucose, toward ATP production, these cells divert their glucose supplies toward fashioning various materials—proteins, nucleic acids, membranes and the like—used to build new T cells that will contribute to further damage.

That shouldn’t happen. Like all cells, T cells contain AMPK, a regulatory molecule that senses ratios of ATP and its two main breakdown products. If it finds ATP too outnumbered by these breakdown products, AMPK clamps down on the T cell’s cell-building program and, instead, sends glucose off to the cell’s ATP-generating apparatus.

“When your house is cold, you need to throw your logs into your fireplace, not use them to build a new house in your backyard,” Weyand said.

The new study provides an answer to the question of why AMPK fails to perform its energy-monitoring function in the faulty helper T cells of patients with rheumatoid arthritis.

To redirect glucose traffic from biosynthesis to internal energy production, AMPK must first be activated. This happens when a small chemical group gets tacked onto AMPK, starting it up like the ignition of a car. That, in turn, can occur only on the outer surface of vesicles called lysosomes.

Lysosomes have a reputation as cells’ garbage disposals because they’re full of cellular debris in the act of being recycled. But they’re more than that. Their membrane surfaces are dotted with all manner of receptors, channels, enzymes and other proteins. Only when AMPK perches on the lysosomal surface and seats itself in a large protein supercomplex there does it get activated and poised to…

You might want to discover another post health just as our similar essay or you probably want to find out over well-liked blogpost, I am always posting that health part frequenlty for suggest together with information moreover ability so supporting our health plus living these healthy lifestyle. This post is posted immediately upon Linda Norton with these title Scientists Identify Reversible Molecular Defect Underlying Rheumatoid Arthritis.

Related posts of "Scientists identify reversible molecular defect underlying rheumatoid arthritis"

Making better embryos

Human Embryo. Credit: Ed Uthman, MD/Wikipedia One out of every six Canadian couples experiences infertility. Some resort to in vitro fertilization. But the embryos obtained through this technique often have defects. In a study published today in the journal Current Biology, researchers from the University of Montreal Hospital Research Centre (CRCHUM) succeeded in reducing the...

Marine snail venom could improve insulin for diabetic patients — ScienceDaily

Although moderately mobile, marine cone snails have perfected several strategies to capture prey. Some fish-hunting species release venom into the surrounding water. Within the plume of toxic venom, the fish succumbs to fast-acting insulin that renders it immobile. As the fish flounders, the snail emerges from its shell to swallow the pacified victim whole. Researchers...

Research shows key function of specialized cells in peripheral nerve repair

The picture shows a mouse nerve bridge tissue section. The pink colour shows cells that express Robo1, the green colour shows Schwann cells. Credit: University of Plymouth New research led by the University of Plymouth has shed light on the science behind peripheral nerve repair, by highlighting the novel function of a cell called a...

Are there health benefits from chocolate?

Every year, Americans spend $22 billion on chocolate, and it's a safe bet that Valentine's Day accounts for a decent percentage of that total. While a heart-shaped box of chocolates may seem like the opposite of healthy, experts say it's less about the occasional small indulgence and more about making good everyday food choices. Most...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.